Bone Marrow Transplantation News

Patients with myelofibrosis who cleared driver mutations within 30 days after hematopoietic stem cell transplantation survived longer and exhibited reduce risk for relapse, according to study results.

Ivan Maillard, MD, PhD, has been appointed head of the division of hematologic malignancies at Memorial Sloan Kettering Cancer Center.

SAN DIEGO — Autologous hematopoietic stem cell transplantation did not benefit adults with mantle cell lymphoma in first complete remission after induction, according to randomized phase 3 data presented at ASH Annual Meeting and Exposition.

SAN DIEGO — The increased use of AI in health care has generated tremendous excitement for its potential to guide treatment decision-making, improve outcomes and increase efficiency.

SAN DIEGO — Socioeconomic disparities affect access to allogeneic hematopoietic stem cell transplantation for people with acute myeloid leukemia, according to findings presented at ASH Annual Meeting and Exposition.

SAN DIEGO — Increased fiber intake after allogeneic hematopoietic stem cell transplantation appeared linked to improved outcomes, according to study results presented at ASH Annual Meeting and Exposition.

Several hematologists will be honored during this year’s ASH Annual Meeting.

I was truly honored to be selected as a scholar for the inaugural ASTCT Laboratory Science Training Course in July.

Clonal hematopoiesis did not occur significantly more often among patients who received hematopoietic stem cell transplantation than their donors, according to findings of a correlative laboratory study.